Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 8

1.

Cancer Health Impact Program (CHIP): Identifying Social and Demographic Associations of mHealth Access and Cancer Screening Behaviors Among Brooklyn, New York, Residents.

Camacho-Rivera M, Rice SL, Oh S, Paris M, Akpara E, Molina J, Obadina M, Mcmillan S, Aracena JLM, Morency J, Muniz RC, Gany F, Brown CL, Gonsky J, Osborne JR.

Cancer Epidemiol Biomarkers Prev. 2019 Mar;28(3):478-485. doi: 10.1158/1055-9965.EPI-18-0788. Epub 2019 Feb 7.

PMID:
30733308
2.

Mogamulizumab versus investigator's choice of chemotherapy regimen in relapsed/refractory adult T-cell leukemia/lymphoma.

Phillips AA, Fields PA, Hermine O, Ramos JC, Beltran BE, Pereira J, Wandroo F, Feldman T, Taylor GP, Sawas A, Humphrey J, Kurman M, Moriya J, Dwyer K, Leoni M, Conlon K, Cook L, Gonsky J, Horwitz SM; 0761-009 Study Group.

Haematologica. 2019 May;104(5):993-1003. doi: 10.3324/haematol.2018.205096. Epub 2018 Dec 20.

3.

Macrophage Inhibitory Factor-1 (MIF-1) controls the plasticity of multiple myeloma tumor cells.

Joseph D, Gonsky JP, Blain SW.

PLoS One. 2018 Nov 1;13(11):e0206368. doi: 10.1371/journal.pone.0206368. eCollection 2018.

4.

Speaking Up: How Patient and Physician Voices Shaped a Trial to Improve Goals-of-Care Discussions.

Solomon R, Smith C, Kallio J, Fenollosa A, Benerofe B, Jones L, Adelson K, Gonsky JP, Messner C, Bickell NA.

Patient. 2017 Aug;10(4):489-501. doi: 10.1007/s40271-017-0226-z.

PMID:
28364384
5.

Thrombolytic therapy is effective in paroxysmal nocturnal hemoglobinuria: a series of nine patients and a review of the literature.

Araten DJ, Notaro R, Thaler HT, Kernan N, Boulad F, Castro-Malaspina H, Small T, Scaradavou A, Magnan H, Prockop S, Chaffee S, Gonsky J, Thertulien R, Tarquini R, Luzzatto L.

Haematologica. 2012 Mar;97(3):344-52. doi: 10.3324/haematol.2011.049767. Epub 2011 Dec 1. Review.

6.
7.

Supplemental Content

Loading ...
Support Center